In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Link
http://www.nature.com/articles/ja201384.pdf
Reference27 articles.
1. Falagas, M. E. & Rafailidis, P. I. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit. Care 11, 134 (2007).
2. Perez, F. et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51, 3471–3484 (2007).
3. Bosó-Ribelles, V., Romá-Sánchez, E., Carmena, J., Cáceres, C. & Bautista, D. Tigecycline: a new treatment choice against Acinetobacter baumannii. Recent Pat. Antiinfect. Drug Discov. 3, 117–122 (2008).
4. Jean, S. S. & Hsueh, P. R. Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens. Expert Opin. Pharmacother. 12, 2145–2148 (2011).
5. Cooper, T. W., Pass, S. E., Brouse, S. D. & Hall Ii, R. G. Can pharmacokinetic and pharmacodynamic principles be applied to the treatment of multidrug-resistant acinetobacter? Ann. Pharmacother. 45, 229–240 (2011).
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing the prodigiosin pigment by adding Ag\TiO2 synergism for antibacterial activity;Biocatalysis and Agricultural Biotechnology;2023-11
2. Synergistic Peptide-Antibiotic Approach to Combat Multidrug-Resistant Acinetobacter baumannii;Jundishapur Journal of Microbiology;2023-10-22
3. Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis;Microbial Drug Resistance;2023-08-01
4. Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study;Antibiotics;2023-01-30
5. Drug Combinations to Prevent Antimicrobial Resistance: Various Correlations and Laws, and Their Verifications, Thus Proposing Some Principles and a Preliminary Scheme;Antibiotics;2022-09-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3